RXMD — Progressive Care Share Price
- $13.49m
- $6.16m
- $49.73m
- 59
- 67
- 21
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.79 | ||
Price to Tang. Book | 1.04 | ||
Price to Free Cashflow | 14.5 | ||
Price to Sales | 0.25 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -134.18% | ||
Return on Equity | -177.59% | ||
Operating Margin | -44.37% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 32.63 | 38.94 | 38.85 | 40.6 | 49.73 | n/a | n/a | 19.23% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- October 31st, 2006
- Public Since
- November 20th, 2008
- No. of Shareholders
- 222
- No. of Employees
- 143
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 6,392,358

- Address
- 400 Ansin Blvd, Suite A, HALLANDALE BEACH, 33009
- Web
- https://progressivecareus.com/
- Phone
- +1 7866572060
- Contact
- Michael Glickman
- Auditors
- Daszkal Bolton LLP
Upcoming Events for RXMD
Similar to RXMD
American Green
Pink Sheets on Nasdaq
Bit Brother
Pink Sheets on Nasdaq
Blue Gem Enterprise
Pink Sheets on Nasdaq
Blum Holdings
Pink Sheets on Nasdaq
Can B
Pink Sheets on Nasdaq
FAQ
As of Today at 22:45 UTC, shares in Progressive Care are trading at $2.11. This share price information is delayed by 15 minutes.
Shares in Progressive Care last closed at $2.11 and the price had moved by -52.58% over the past 365 days. In terms of relative price strength the Progressive Care share price has underperformed the S&P500 Index by -63.13% over the past year.
There is no consensus recommendation for this security.
Find out moreProgressive Care does not currently pay a dividend.
Progressive Care does not currently pay a dividend.
Progressive Care does not currently pay a dividend.
To buy shares in Progressive Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.11, shares in Progressive Care had a market capitalisation of $13.49m.
Here are the trading details for Progressive Care:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: RXMD
Based on an overall assessment of its quality, value and momentum Progressive Care is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Progressive Care. Over the past six months, its share price has underperformed the S&P500 Index by -15.54%.
As of the last closing price of $2.11, shares in Progressive Care were trading -11.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Progressive Care PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Progressive Care's management team is headed by:
- Alan Weisberg - CHM
- Cecile Munnik - CFO
- Birute Norkute - COO
- Joseph Ziegler - DRC
- Oleg Firer - IND